Business as Usual: Generation Fempreneur

Transcription: 

Good afternoon, everyone. Welcome to business as usual today we have a very special event in partnership that I'm going to talk about. I'm Audrey, I run the Pittsburgh tech Council and thrilled to be here with Jonathan Kersting. He's vice president of all things media. And he makes sure that we're telling stories and doing all the things of shining the light on Pittsburgh, he'll be moderating the chat and making sure that we're not overlooking anything. So I want to give a shout out to Huntington bank, they've been our partners right from the onset. And from the onset, meaning we've been doing this since March, and we are now in December, we took a few days off, but now we're back. And we're pretty excited about today's program. And about the partnership, I also want to give a deep appreciation to the Jewish health care foundation. It's the Jewish health care Foundation, if you don't know anything about them, I just want to set the stage a little bit, because I think it's important they have three arms, and their operating arms, they have the Pittsburgh Regional Health Initiative that they refer to as PR h i, they have health careers futures, which they call HS h CF, and the women's health activist movement global. And that's w h m global, we'll put the links out there. So you can, you can, you know, go through them and see the kind of work that they're doing, because it's a lot. They offer what they like to refer to as a unique brand of activist philanthropy to advance healthcare innovation, advocacy, collaboration, and education in the interest of better population health. They have been our partners and in many different ways over the last few months and issues that we've grappled with as a region. They've given us advice and perspective on matters that are tied to COVID. As well as issues that are tied to safety. And I think if you go to their website, you'll get a rich understanding about all the things that they work on and the innovations that they have. So they are their partner and sponsor today. And also 40 by 80. That's our nonprofit entity of the tech council that's leading many of our efforts that are tied to entrepreneurship, as well as workforce and talent development across our region. So we have muted your microphones. We don't want to hear what's going on in the background. And but we have a chat, as I mentioned earlier, so please use this opportunity to ask questions, you're going to be really impressed with Elizabeth, who's going to join us in a minute. So I know there's going to be lots of questions. And this is not an opportunity for you to sell your wares. And for any kind of advertisements. That's not what today is about. We do that and other days today when we do this work we don't. So I mentioned this as a joint program with the team at liftoff PGH. And I and I want to bring to the forefront, Megan Butler, from that team. She's going to tell you about the program. And then she's going to do a quick intro to Elizabeth and and Elizabeth has a lovely title. And I'm not going to script it. Because I want Megan, actually to be intro. So Megan, please introduce yourself. Thank you so much for being such a great partner. And, you know, pushing the agenda, all the matters. And we're very lucky to have our guests today. So Megan, welcome.

Thank you, Audrey for that lovely introduction. Like Audrey said, I'm Megan Butler, and I'm an innovation associate with the Jewish health care Foundation, working on liftoff PGH 2020. And we're so excited to be partnering with the Pittsburgh Technology Council in business as usual on today's session. For those of you who haven't heard of liftoff PGH. We are a two week long virtual summit that actually kicked off officially just yesterday. We're really excited. We have programming happening on a daily basis leading up to December 15 and 16th. Those two days are going to be full day live broadcasts. But leading up to those days we have bits of programming going on on a daily basis. The goal of the virtual summit is to help prepare the Pittsburgh region for the future of healthcare innovation. So it's a very regional initiative really focused on how we can leverage our assets here to position the region to be as strong as it can be in the future. So we hope that some of you will consider joining us I see that Alexis posted the link to our website in the chat. So we hope that you take a look at our website to learn a little bit more and if you're interested. Registration is still open even though we did officially launch yesterday. So Anybody who's interested in registering can do so using the link in the chat. So we're really excited for today's session, we actually started our partnership with the tech council over the summer on this series of webinars called generations on printer. So we're really excited to have our encore session of generation found paranor today with Dr. Elizabeth Payne. And we have another Jeff, printer session next week on Wednesday as well. We hope that you'll join us for that as well. But with that, I'm really excited to introduce our guests for today, Dr. Elizabeth Wayne from Carnegie Mellon University. Elizabeth is an assistant professor of biomedical engineering and chemical engineering at CMU. And her work focuses on immunotherapies immuno engineering, and how that can be used to fight specific disease states, including cancer and COVID-19. So we're really excited to hear a little bit more about that today.

Thank you. Thank you so much. And Dr. Elizabeth Wayne, would you like me to call you Dr. Wayne? Elizabeth?

I think you'd call me Elizabeth.

Yeah. Yeah. So wonderful to just meet you for a few minutes before and I'm very excited.

Call me list.

This call you list. Okay. So thank you is for joining us. So could you please just set the stage so everyone understands. So who you are, but that was a lovely introduction, in terms of your work. But you know how long you've been in Pittsburgh, what your passion is, and then we're going to jump into some questions.

Wonderful. Well, it's so great to electronically meet all of you guys. I'm very excited to be in Pittsburgh. I have been here since August 2019. Yesterday was my first real snow that I'm counting last year because that ever fell on the ground last year didn't count. I think you guys know this. And, but I'm originally from Mississippi. And so I always find this interesting to kind of start off with many people. I've never met someone from Mississippi and I don't have a southern accent. It kind of comes when I get back with my family. Yeah, but, you know, Mississippi is a great place. And I really appreciate my upbringing there. I'm so passions, a lifelong nerd. I think lots of things are interesting. I love falling the interesting questions. And I have I studied physics and undergrad, and then I went to biomedical engineering. And then I did a postdoc in pharmacy. So it makes perfect sense that I'm like a professor of biomedical and chemical engineering right now, right? Like That was a perfectly linear leap. But I fell in love with physics, I thought it was a great way to understand the world around me that physics was the physical understand the physical world around me. And then math was the language of physics. So the map of the physical world, yes, lifelong nerd. I told you that. Yeah. And then I started using that to do imaging. And I really became interested in how do we use physics principles? Like how does light travel through material to then understand how to make images of your body? And then that led to Well, now they know how to make microscopes, how can I image this, and I became interested in cancer, and trying to track your immune cells as they track cancer. So what is interesting about this is that cancer in cancer 90% of cancer deaths are related to the spread of cancer. So if you can stop that spread, maybe you can stop, slow down cancer. And then I thought, well, your immune cells are on already in your body, they should really know what's happening, because how do they determine when a cancer cell is there? And how they recognize it? And do they try to kill it? And then how can you develop drugs around that. And then that led into even more research and a collaboration. Working on using immune cells is what I would call Uber drivers. Like you can put the drug on the cell, and then the cell just goes around and does whatever it's going to do. And now you just kind of given a superhero cape. So it would kind of be like, whether you're using your own GPS and walking around New York City, or whether you trust that taxi driver that knows like how to get from 56 to 48, in like two minutes, because they know the back ways your immune cells are those cells. And so once I started seeing the real utility of how immune cells can migrate to your body, they know where everything is, they have their own friend networks and know how to communicate, they can go on road in the bloodstream, then you go off roading your orthotic vessels, they just know the terrain super well. And then I thought, Well, how do you actually try to use materials that can modulate them? What if instead of just saying that you want to put the drug on the on the cell, but then let the cell do it, it normally would do to then say something more active. I want that nanoparticle or that drug to actually change something about the function, not too sure about the NYC. Something about the function of that cell. So then it does Something that we actually wanted to do as in, what if we can actually make nanoparticles that say, no cell, I want you to now go to the lungs, or I want you to stay away from the lung. Or when you get there, I want you to be to have more killing activity, or I want you to be more proliferative. And that is kind of the beauty of amino engineering, which is that you're now trying to introduce all these principles of engineering that we've got from chemical material science, mechanical engineering, and saying how we apply that to me ology.

So here you are you you're at Carnegie Mellon, you decide that you're going to come way up north. And you know, we love having you here just by listening to your preamble there. I'm thrilled. But in June, it's not. But and in June, yes, you were awarded an NSF grant to apply your research in immuno engineering to the COVID pandemic. Yes. So give us an update. And how did that happen? And, you know, what are you doing? Tell us a little bit about that? Um,

yeah, well, you know, I think this is a real entrepreneur, like question. So one is a precursor. I'm not quite sure what if people know what professors do, in a way, we actually are CEOs of a small startup company. And what I mean by that is, I pay a part of my own salary, I pay my students tuition and salary and stipend, I have to apply for grants to get funding. And so you're always looking for figuring out like, what type of space do I have? What skills expertise do I have? And who needs that expertise? How can I apply them? And they're always also thinking, How do I re innovate myself? How do I adapt what I have to the current challenge? And so in that case, this became a question of COVID. So I told you about my interest in macker. In immune cells, my favorite one is the macrophage. Because they, um, and my friend analogy, they're the, they're the type of immune cell that they do with the friend group does. So they kind of like, they're like your calm friend, where they're like, okay, don't get mad at Jen, she just has this thing she wants to do, you know, and, you know, you have to understand, Steve, he just doesn't want to go out, let's just help each other out. Which means that you can really tailor their responses based on what they see in their environment. And so if you artificially create something in their environment, then you can say you can make them sway one way or the other. So these cells are also interesting, because every organ in your body has their own specialized type of macrophage. And by the way, macrophage is Greek for big eater. They actually like to phagocytose things, they like to eat things. So when you have an injury, they either wanted to eat up all the dead cells, but they also convert to become wound healing, that promotes angiogenesis. So new muscle group. So again, they have the ability to switch between one phenotype and another, which makes them really exciting for me. Now, in COVID, what happens is that if you do autopsies, from patients who succumb to COVID, they're filled with macrophages and monocytes.

Mm hmm. Yeah,

yeah. And so I thought this is interesting. So what's happening and there's also this connection. Um, if we go back to the friend analogy, and the macrophages are the people who can be either a pro activity or pro relaxing, I will call them these two phenotypes, what happens think about what happens when your basic friend and one who's kind of agreeable is no longer in the friend group. It's complete chaos, because no one's trying to agree with each other, no one's talking and the whole friend group eventually dissolves. And that is actually what happens in your organs and during disease. So if you were to look at cancer, neurodegenerative diseases, like Alzheimer's, and Parkinson's, diabetes, and even in wound healing, the inability for your body to heal after a heart attack or stroke, those macrophages are not in their right phenotype, they're not behaving properly. And the same thing is happening for COVID. And so in patients that have pre existing conditions like diabetes, their monocytes, and their macrophages are not behaving properly anymore. They don't, they don't really go with the flow of their friend group anymore. They're overreacting to things or they're under reacting to things. And they're just letting everything get out of control. So when Mac phages are exposed to the SARS Coby virus, and they're already not behaving properly, they have an over reactive response, which means they actually take everybody to the lungs and they secrete more cytokines that are toxic that make other toxic things happen. And so instead of saying, Oh, wait, I should actually support my conference to promote suppression they end up supporting the That's super active and always wants to go out all the time. And then before you know it, you have no more money. It's like the hangover, there's a tiger in your bathroom. And you're like, what is happening? And that is what's happening in the lungs because of COVID. So now thinking about what the monocytes do, it becomes important to now think, well, how can we apply any and, you know, engineering principles, to think about how we can kind of control that response. And that was what I was awarded this NSF grant to do. Two things, the first was to actually confirm that we don't quite understand why people have pre existing conditions have worse mortality, or they have worse symptoms from COVID. And I think it's the macrophages. So we're looking at that. And then the immuno engineering question for me becomes, well, now that we know this, how does that change any therapeutic pursuits that they have? So if the macrophages are not responding correctly, to normal responses, and I guess the the, if I were to give an analogy here, your immune system as opposed to respond to things that are out of place that are out of order, and I would think of this as if you and a friend are walking down the street, and you see a puppy, or maybe it's a baby, for some people, it's a baby, for me, currently, I'm in baby fever right now. Or it's like a sale at Costco or something? I don't know. Okay, normal person would say, oh, there's a sale, that's nice. And they'll just keep walking, okay. And overreactor response would be for someone to literally go touch someone's baby to just like, have this dog lick their face, and just like they don't know how to walk away. Okay, so the question is, how do we actually build materials, or responses that can actually get that macrophage that's having an overreactor response to walk away? To walk away from the sale, or the dog or the baby before they committed any crimes?

Wow. So you're doing this research? How long is this NSF grant for?

So the grant that I won is called a rapid and these are actually released under special circumstances. So whenever there's some sort of major national crisis, the NSF will provide emergency funds. And athletes, they want you to do things rather quickly. So this grant will last one year. And then I will follow up and give the report. So the results, what I hope to show and we're kind of halfway there, as to show that one, the monocytes are impacted. They have worse prognosis. And to also relate this to antibody production, there's another question about whether people are generating the appropriate antibodies. And so along those same lines, if your immune system is not performing correctly, if they're having the regular, overreacted response, it messes up every response that you have, whether it's over producing those cytokines, or there's not producing the right type of antibodies. And it can have long lasting implications. So there's a biological standpoint, I'm trying to understand. But the other thing is also, can we design drugs as typically target macrophages that are diseased? So the analogy if we go back to that dog analogy, right? If you want to get a normal person not to pay into a dog, they already weren't paying attention to it, you probably don't have to do that much should to the situation to make that normal person keep walking. Right? Whereas if you gave that normal response to the overactive person, they would probably just walk right past it, right. You wouldn't need like a bigger blinder. Maybe a larger dog, I don't know, you would need something else. And so that's something else is the kind of biomaterials question I'm trying to answer. How are the uptake pathways different? How the activation different? And how can you reverse engineer materials that can talk to kick that can be targeted, specifically to these drugs? Or to these mean sales? Wow.

So thank you so much, I love your analogies, and I'm never gonna be the same when I walk down the street. So I'm always thinking about this. So thank you. For that I saw for the dogs, the puppies and the sales. So you said you had been very vocal in the role of education in providing opportunities from people in you know, backgrounds that haven't had access. Can you tell us more about your own role in in early childhood or in education, that sort of how it affected your own career path?

Yeah, and my mom is a school teacher. And so one, I think I've always had this appreciation for how hard they work or how little they get compensated for that work. It's a very difficult job. Um, I also had the experience of going to several different schools within Mississippi. So I started elementary School at a school that was actually on probation. And really, it wasn't very good. 25 miles away, there was a school that was just like, people were doing much better. And I really got to see what a difference geography made to the type of education people received. Um, that was really cemented to me. And it was also kind of something of learning about what socioeconomic status, race, gender, really play into these types of perceptions. For whatever random reason, I want to be a physicist when I was 11. There was this chapter on atoms, and I never heard of an atom before. You know, we talked about the sun and the moon, like, okay, that's cool. Yeah, there's like nine, okay, there, there were nine planets. And now there's a planet and a satellite. But at the time, I thought, like, atoms are so cool. And then there's this chapter about. And if you like, push the atoms together, like fusion, they release energy. And then if you also split atoms, then you also release energy. And by the way, those are the atomic bombs that hold change our whole world as we know it today. So I was super excited about that. And when I was in sixth grade, I decided to do a science fair project. And then I decided to do a nuclear fusion and nuclear fission. is pretty stupid. When I think about it. I was like, I'm not doing a hurricane. I'm not doing like, like the volcano thing. That's just like, that's over done not doing a barometer. I did that last year. I'm gonna like literally try to build there, I'm gonna build a makeup reactor because I think this cost millions of dollars, I don't have the kind of access. So in like, early 2000, I was literally googling, like, Where's the uranium 235? And like, how do you find these things in the library internet because we didn't have internet yet. So yeah, I have really grateful I didn't try to do that. Now, I really think that I would have been arrested for the types of things I was doing. Um, but I love science. I love physics. And I kept saying, I want to be a physicist. And we didn't have physics at my high school. And we didn't really have like, good math at my school. We didn't go all the way up to like AP calculus and things like that. So I really got a great opportunity. When I went to the Mississippi school for math and science, there are 14 states in the country that have these residential public math and science schools. And I apply my sophomore year and I got in. And really what made the difference for me was like, they had the course catalog had like four physics classes. And I was like, Well, if I'm going to figure out if I could be a physicist, I have to, like, take a physics class, I have to, because I've read all I can in my, in the library books and stuff. And my internet searching is starting to, you know, lead to not looking at physics things. Um, so I did that. I got really great experience with physics, and still loved it so that I went to school and I did that. So I guess the whole I knew I wanted to do something I think I'm kind of naivety is good, because when you don't know how hard something's going to be, you don't stop yourself from trying to do it. And so I'm grateful that I was I had this naivety. And I'm grateful that also kind of had a little bit of like hardheadedness because people will always tell me like, What do you know? Oh, you're good at math and science, your girl like, that's interesting. Or like, being the only black person in my class. Like, it was really challenging to hear people kind of expressed these doubts, but then I kind of treat it like an experiment will like, well, what day do you have support that claim? Absolutely. None. So I'm just going to keep doing this thing to figure out whether I want to do it or not. And undergrad, I was the only black person. And I was only woman in my classes. All four years at at Penn. I went to Penn for undergrad. And so, uh, yeah, that was interesting. Um, but I think, I think if you guys are any, if there are any science people in the room, I think, you know, there's kind of a science culture of nerdiness, which, like, I related to very much. It's just that like, I guess what I would say is, we sort of sometimes glorify

I don't know, the guy who kind of wakes up with bed here and like runs a class and it's like, really disorganized, but they have the glasses and it looks super smart. And it's like, what's it look like when it's a woman? Right, if what is it and what is it like when it's a black woman? Right? So there's so many different layers to like, What does like crazy genius like, really likes like anime or whatever the things are that you know, you think nerds kind of culture is or like, is reading about firemen or like doing like chess puzzles and stuff. So I think that having this representative As in matters, does, it really matters and actually thinking about the intersections of power here.

Now, I mean, your candor is is just delightful. I love the way that you break it down for for all of us across the array of, of Science and Technology. You have also put together a podcast and a podcast called pH divas. Yes. And talk about that, just talk about that. And then just tell us what the link is. And we can, and we can share it.

So you can find PC podcasts on iTunes, I don't think we put on Spotify. But we can do that PC with WordPress, it's on SoundCloud. Like if you google p, she was by cache with my co host. And I started this when we were graduate students at Cornell. And what I find fascinating about it is it's two women of color. So the other host is a an Asian woman. She's British, she's Canadian. And she has a PhD in English. And she's now actually the equivalent of a professor at University College of London. So what's funny about it is that when she was growing up, and she was like, the top English person in your English class, and people would tell her, but do you speak English? And he's like, yeah, I speak English. And actually, like, I'm the best person in this class. And I'm like, Oh, my God, I used to tutor my Asian friends and bass, this is so cool, like reverse the gift. This is like, so we were both good at things that people didn't expect us stereotypically to be good at. But we talk a lot. So what we do with the podcast now is that we try to amplify voices of women in higher education. And it's really broad. It's whoever is pursuing higher education. So some people have degrees, some people don't PhD masters is kind of spans the gamut. And this was really just a conversation with a friend. And we just kind of talked again, we started as a grad students, and now we're both faculty. So just kind of wild to think about, and what it has become, I think, is a really great opportunity to provide exposure. So this idea that women are not often represented as experts and media is probably not new to any of you that the people who have called on to be experts are often not women of any ethnicity. And I think having I started to notice when we interview people that they were nervous that they were like, I'm not an expert, I'm like, I'm sorry, what are you studying? And Indigo bla bla, bla, bla, bla, bla bla, I'm like, Okay, I think you know, what you're talking about, like, I think you can talk about this, like, you know, X ray, this like, really, really mundane receptor. And this really, really complicated disease or like you say, 19th century literature about Arkansas, or like someone you actually study, Confederate statues, you study, migration, you, you know what you're talking about. And I think giving people that opportunity to have a platform to share their knowledge, which literally leads to other people finding out about their work, and giving them that taste of like, a safe platform to, you know, understand, they're actually experts.

Well, that that was essentially gonna be the question that I was going to lead into is sort of what is your advice, and I think you have created some contagion there and all of your models. So here you are in Pittsburgh, and we in the across the tech community, want to figure out ways to get better get wiser and support your work and people that are needing your kind of work. What's your advice? What do you what do you want to ask of us who've been here a year? Ask us and what is there anything about Pittsburgh that has surprised you? Oh, that's

like three questions.

I know. I always do that. I like to pack

it right in Hackett right in. The first thing about asking what can about what can be done? I find thinking about, um, what are the challenges that may not be in where the unintended consequences and think about the messaging and how that might? Who are you unintentionally, unconsciously or consciously asking to do things? And who are you unintentionally not asking to do things? So I think there's a bit of awareness that has to play into this. An example would be the tail, the traditional like, you want people to be able to warm introduction or talk to each other. But what if a lot of that talking happens in male dominated spaces? What if it happens at the bar? What if it happens in the men's restroom like I don't understand that personally, why you talk to each other like that. But apparently things like that happen. I've heard Well, the woman can't follow you into the bathroom. And some women do not like to drink and actually even men, some men are not huge drink. Or like, Please don't make me have to go hiking the guy to get to know you, you know? And so just thinking about, like, what types of activities are we doing? And how are they actually probably excluding people in ways you may not think of. And sometimes my acts will be financial, and structurally based in and just to, I would argue to get away from this idea that it's an a personal assault on you like, it's not about the goodness of your heart, we think everyone can be a great person and still participate in kind of structural racism or sexism or benevolent sexism. And I think those types of conversations are important to just think about moving forward. And in the reality that, that even I know, I've been in the Ivy League. So I've been I have had tons of access. But I can also tell you that the barriers, we still have a lot as many women in entrepreneurship. And when you think about the people of color, including women of color, who get access to Angel and angel investing, or venture capitalists, like there are a huge divides in that. And there are some structural reasons behind that. So I think thinking about that.

The other question is, what

can I do here, and what I want to think about Pittsburgh, so I've been thinking about entrepreneurship a lot and tech transfer. amino therapy is really fascinating space, because it's so deeply connected with institutional research, that there's a huge opportunity to do startup entrepreneurship, and all those types of ventures that I see happening in other spaces in the US, biotech is also high risk, high reward. And so it's a bit different than a software company startup, right, and the type of investment that it takes. But nonetheless, I still think is interesting to kind of in to get scientists involved to get MBAs or people who are interested in business and marketing involved, and also to get that leadership from experienced CEOs who have had companies before and kind of want to give back. So one thing I think about is Pittsburgh, I knew it as a steel country, I know. But what I've learned is that you guys are we are we have me re envisioning our space. And healthcare has become a huge sector here. That is, in some ways help to compensate for the loss of steel work, still jobs. I also tech is moving in and in particular automation. And so the question for me that I think is interesting is like, Well, is there space for Pittsburgh to become one does immunotherapy research hubs in tech hubs where you would see in Seattle, which is done a really great job of combining engineering and hospitals there with the startup companies that have been allowed to have this really amazing ecosystem, to have the jobs that you need there? So those are kind of the questions that I'm interested in. Particularly because, as a faculty, part of my job to do research, right, I have this small seat tech that if I don't get money, I will get fired, you will not have a business anymore. But I also want to produce scientists who are kind of civic minded, and who also know how to take ownership of their science. And I've seen a lot of times where like scientists like you need a job after this. What if that job, we're launching your ideas that you started here? How do you take advantage of those opportunities? So I think I kind of think we're interested in doing a good job

at answering all three of them, you did a great job, I am sorry that we have to bring the show to a close. But I have learned a tremendous amount, a tremendous amount, the way that you have broken down, you know, the whole sort of basis of immunology, and the fact that you are here in Pittsburgh and at Carnegie Mellon and very interested in entrepreneurship, and breaking down barriers. I really appreciate your candor, and just your dynamism in terms of United about the future. So we are going to keep in touch. Yeah. This we're gonna keep in touch. And if people want to reach out to you, what's the best way for them to find you? I'm

email. I'm also for social media, people. Twitter at Liz Wayne, PhD.

Okay, we'll follow you. Yes,

you can follow me on Twitter. You can also email me as he should I put it in the chat box or No? Okay, I'm just gonna write it in the chat box. But it would be great. That's Twitter today, email. I mean, this is easily searchable. So, okay, but he Wayne, and then there's the PhD was podcast. We also did the COVID episode. And I have to say it's been really great to connect with people. So if I have questions about things, I just go ask someone back in interviews. That's great.

That is great. So I want to thank liftoff and the team at the Jewish health care foundation. Thank you, Megan. So much. for your support, I really look forward to it, I am going to keep track of Dr. Elizabeth Wayne. And because I think she's helping me understand some of the basics of physics in a way that perhaps I haven't been able to articulate

and how to be more fun, didn't you?

It's a lot of fun. It's a lot of fun. And just thank you for being a leader. And, you know, being pursuing your dreams. And that matters to each and every one of us. That's the matter, no matter where we sit in our lives. So, you know, late Welcome to Pittsburgh, but we're gonna stay connected to you. I want to thank everyone, for joining us today. And Megan, next week, we're going to do another lift off on Wednesday. And we're very excited about the partnership and the work that they do. We think we've shared a lot of information today. And my hats off to Dr. Elizabeth Wayne for doing the work that she's doing right here in our backyard. So I want to thank everyone. Thanks for joining us. And again, thanks to Jewish health care Foundation, as well as their program. Liftoff. Take care, everyone. We'll see you here. Jonathan, who's here tomorrow. Well, tomorrow we have the Air Force has a very special project that talks about some flying cars. So we'll leave it at that right.

That might be cooler than what I just told you.

Yeah, almost as cold we were talking about

is cool. But Liz, you can join in anytime we do this every single day. And it's a great way for you to know what's happening in the region. It has been a delight. It has been a pure delight. Thank you for having me. Thanks, everyone. We will see you tomorrow and stay safe.

Thank you

Transcribed by https://otter.ai